Metadata
- Name
- SOX Combined With Sintilimab and Trastuzumab in the Perioperative Treatment of HER2-positive Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
- Repository
- ClinicalTrials.gov
- Identifier
- clinicaltrials:NCT05218148
- Description
- The SOX regimen has became the standard perioperative chemotherapy for locally advanced
gastric cancer; The immune checkpoint inhibitors have become a standard treatment for
advanced or metastatic gastric cancer?For HER2-positive locally advanced gastric cancer, some
phase II studies have shown that chemotherapy combined with trastuzumab can further improve
the pathological remission rate;This prospective phase II clinical trial was designed, using
SOX combined with sintilimab and trastuzumab to treat HER2 positive locally advanced gastric
or gastroesophageal junction adenocarcinoma patients. - Data or Study Types
- clinical trial
- Source Organization
- Unknown
- Access Conditions
- available
- Year
- 2022
- Access Hyperlink
- https://clinicaltrials.gov/ct2/show/NCT05218148
Distributions
- Encoding Format: HTML ; URL: https://clinicaltrials.gov/ct2/show/results/NCT05218148